Skip to main content
construction release_alert
Profile editing is temporarily unavailable from June 11-24, 2026 while manual profile data entry transitions to Elements. Learn More.
cancel

Victor J. Dzau

James B. Duke Distinguished Professor of Medicine
Medicine, Cardiology
Victor J. Dzau Laboratory Gsrbii # Room 4015, Duke University, Durham, NC 27710
Victor J. Dzau Laboratory, Gsrbii # Room 4015, Durham, NC 27710

Current Appointments & Affiliations


James B. Duke Distinguished Professor of Medicine · 2005 - Present Medicine, Cardiology, Medicine
Professor of Medicine · 2004 - Present Medicine, Cardiology, Medicine
Professor of Pathology · 2004 - Present Pathology, Clinical Science Departments

In the News


Published June 11, 2014
Editorial: Victor Dzau’s legacy
Published June 10, 2014
Dzau looks back on tenure at Duke
Published April 11, 2014
Academic health care systems facing additional complications

View All News

Recent Publications


Hemoglobin inhibits fibroblast-to-cardiomyocyte reprogramming via TLR2/TLR4-dependent chromatin compaction.

Journal Article Mol Ther Nucleic Acids · June 16, 2026 Fibroblast-to-cardiomyocyte reprogramming is influenced by signals present in the injured heart. However, the nature of those signals is unclear. The efficacy of fibroblast-to-cardiomyocyte reprogramming was found to be negatively impacted by extracts deri ... Full text Link to item Cite

Engineering extracellular vesicles for targeted therapeutic delivery in the heart.

Journal Article Biosci Rep · April 22, 2026 Heart failure is a leading cause of morbidity and mortality, highlighting the need for improved therapeutic strategies. Critical to the success of therapies is efficient and targeted delivery systems. Extracellular vesicle-based delivery systems have emerg ... Full text Link to item Cite

Cardiovascular Science, Medicine, and Society: The Brave New World: The ACC Braunwald Lecture 2025.

Journal Article J Am Coll Cardiol · April 21, 2026 Recent scientific and technological advances have dramatically expanded the possibilities in cardiovascular medicine. Landmark clinical trials have introduced transformative therapies for lipid disorders, heart failure, and obesity, offering clinicians pow ... Full text Link to item Cite
View All Publications

Recent Grants


Novel approaches for cardiac reprogramming: Exosome delivery of reprogramming miRNAs and repressor targeting siRNAs

ResearchCo Investigator · Awarded by National Heart, Lung, and Blood Institute · 2025 - 2029

Mandel 2024-2027

ResearchPrincipal Investigator · Awarded by Edna and Fred L. Mandel, Jr. Foundation · 2024 - 2026

Mandel 2021-2024

ResearchPrincipal Investigator · Awarded by Edna and Fred L. Mandel, Jr. Foundation · 2018 - 2025

View All Grants

Education


McGill University (Canada) · 1972 M.D.